echemi logo
Product
  • Product
  • Supplier
  • Inquiry

    blazed

    Get the latest blazed news delivered straight to you. The information of blazed is large on echemi.com.
    • Eli Lilly/GSK/Vir jointly announces expanded Phase 2 BLAZE-4 test top-line data

      Time of Update: 2021-04-24
      In addition, in terms of the key virological secondary endpoint of the new coronavirus (SARS-CoV-2) viral load from baseline inspection to the average change on days 3, 5, and 7, compared with placebo, the combination of bamlanivimab and VIR-7831 The use of the drug resulted in a statistically significant reduction in viral load.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.